VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Voyager Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.05+0.15 (+7.89%)
Close on Oct 19, 2026
- Market cap
- $124.12M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Voyager Therapeutics has not reported a dividend
No dividend per share appears in Voyager Therapeutics's annual filings since fiscal 2013.